Therapy

Novel cancer vaccines report presented at Therapeutic Vaccines European Congress 2002

Published in Vaccine Weekly, August 7th, 2002

Biomira, Inc., (BIOM) (BRA) announced that a Biomira company representative presented at the Therapeutic Vaccine European Congress 2002, London, England. The Congress focused on therapeutic vaccines and assessed the market potential and define the critical steps towards profitability for companies working in this field.

Guy Ely, MD, vice president, clinical and regulatory affairs, provided insight on Biomira's therapeutic vaccine program in a presentation titled "Theratope Vaccine-A Case Study of the Journey from Bench Top to the Final Phase of Clinical Testing."

"We are pleased to share our many years of experience in developing cancer vaccines. ...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2002-08-07)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry